Biotech Values

[DewDiligence]

PSI-938 may turn out to be a fine compound, but GILD made it clear that PSI-7977 far outweighs all other VRUS assets in arriving at the $11B buyout valuation. If I had to put a number on it, I would say that 95% of the buyout price is attributable to PSI-7977.